Stemtech Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 4.56 million compared to USD 4.32 million a year ago. Net loss was USD 8.54 million compared to USD 7.08 million a year ago.

Basic loss per share from continuing operations was USD 0.19 compared to USD 0.2 a year ago. Diluted loss per share from continuing operations was USD 0.19 compared to USD 0.2 a year ago.